To be fair, those bio-science start-ups sporting market caps of $500+ million with no revenues are backed by large pharmaceutical companies. Those start-ups are engaged in FDA clinical trials that involve 5 stages (phases 0-4).
It takes millions, if not tens of millions, and years to complete all the 5 stages of the FDA approval process for a clinical trial. The market looks favourably at any drug/method/process approved beyond stage 3, thus insane prices for some of those start-ups.
Fuse is not conducting an FDA clinical trial for a drug, but for dietary supplements. Dietary supplements (isolated nutrients from food or herb) are not under FDA review as long as they do not make any claim of being able to treat or cure any illness or disease.
Right now most drugs and supplements are delivered through the gastrointestinal tract (pills, capsules, liquid) and through the bloodstream via injection. If Fuse's delivery system works, you could imagine the potential.
One application I could see is for someone who has a sore throat after yelling "disaster" all day. Rub the concoction on the throat and let the Drop Technology do the rest.
News 
Market Data 
Discover 
AI
